Driving Innovation:
V||V Healthcare's Long-Acting Pipeline
Assets in development target multiple stages of the
HIV life cycle with expanded dosing options
Binding & Fusion
X
Binding & Fusion
Class: Broadly Neutralising Antibodies (bnAbs)
- VH3810109(VH - 109) - N6LS - Phase II
Mechanism of Action video - VH4527079(VH - 079) - Bi-specific - Pre-Clinical
- Bibliography
Nuclear Entry & Uncoating
X
Nuclear Entry & Uncoating
Class: Capsid Inhibitors
Mechanism of Action Video- VH4011499(VH - 499) - Phase II
- Bibliography
Integration
X
Integration
Class: Integrase Inhibitors
- CAB-ULA (Cabotegravir Ultra Long Acting) - Phase I
- VH4524184(VH - 184) - Phase I
Barrier to Resistance Video - VH4367310(VH - 310) Pre-Clinical
- Bibliography
Assembly & Budding
X
Assembly & Budding
Class: Capsid Inhibitors
Mechanism of Action Video- VH4011499(VH - 499) - Phase II
- Bibliography
1Binding and Fusion
Class: Broadly Neutralising Antibodies (bnAbs)
- VH3810109(VH - 109) - N6LS - Phase II
Mechanism of Action video - VH4527079(VH - 079) - Bi-specific - Pre-Clinical
- Bibliography
2Nuclear Entry & Uncoating
3Integration
Class: Integrase Inhibitors
- CAB-ULA (Cabotegravir Ultra Long Acting) - Phase I
- VH4524184(VH - 184) - Phase I
Barrier to Resistance Video - VH4367310(VH - 310) Pre-Clinical
- Bibliography
